Leading colorectal cancer expert from Oxford discusses recent advances in colon cancer treatment. Multidisciplinary Team (MDT) approach to evaluate colorectal cancer patients is the most important advance in colon cancer therapy.
Transcript of video
Colorectal cancer treatment advances. Dr. David J. Kerr, MD. Multidisciplinary Team of colorectal cancer experts determines precise diagnosis and formulates personalized comprehensive treatment plan. This is the best colon cancer treatment approach. Dr. David Kerr introduction (Oxford University. Colorectal cancer treatment requires multidisciplinary team, MDT. Dr. Anton Titov, MD. Advanced stage 4 colon cancer chemotherapy options are discussed by multidisciplinary team before treatment starts. Second opinion confirms that colorectal cancer diagnosis is correct and complete. Second opinion also confirms that cure of colon cancer is possible even in advanced colon cancer. Multidisciplinary team selects best treatment for advanced stage 4 colon cancer with metastatic lesions. Second opinion helps to choose precision medicine. Dr. David J. Kerr, MD.Receive the best targeted chemotherapy treatment for stage 4 colorectal cancer with liver or lung metastases. Dr. Anton Titov, MD. Get second opinion from international multidisciplinary team on advanced colorectal cancer. Be confident that your treatment is the best. Best colorectal cancer treatment center for personalized medicine. Video interview with leading expert in metastatic colorectal cancer treatment from Oxford. Colorectal cancer treatment 2015 advances. Dr. Anton Titov, MD. Hello! Today we are with Dr. David Kerr, who is Professor of Cancer Medicine at University of Oxford. Dr. Kerr is also former President of the European Society for Medical Oncology. Dr. Kerr received his MD from University of Glasgow. Dr. Kerr did his post-graduate training in clinical oncology and cancer research at several leading UK and the USA institutions. Dr. Kerr has large experience in public health and policy. He served as health adviser to the UK Secretary of Health. He also served as Chief Research Advisor for Sidra Medical and Research Center in Qatar. Clinical and research interests of Dr. David J. Kerr, MD are in colorectal cancer genetics and treatment, and in cancer treatment organizations in the emerging markets. Dr. Kerr is an author of over 300 peer-reviewed scientific articles on cancer genetics and colorectal cancer. Dr. Kerr, hello and welcome. Dr. David Kerr, MD (Colorectal cancer oncologist, Oxford). Thank you very much for that warm introduction. Dr. Anton Titov, MD. Colorectal cancer treatment changed dramatically over the last decade. What are the major recent advances in colorectal cancer treatment? Dr. David Kerr, MD (Colorectal cancer oncologist, Oxford). Over the past decade one of the most important colorectal cancer treatment achievements have been improvements in multidisciplinary teamwork to treat colorectal cancer. Previously each of the different specialties – surgery, oncology, radiation therapy – worked separately to treat patients with colon cancer. Now we work as fully integrated teams to treat colorectal cancer. Dr. David J. Kerr, MD. There is no doubt that decision making is better in multidisciplinary team approach to colon cancer and rectal cancer. The quality of colorectal cancer surgery has improved, particularly for rectal cancer. The quality of pathology reporting is better. Pathologists give us information we need to make better colorectal cancer treatment decisions. Dr. Anton Titov, MD. In medical oncology we have some useful new medications to treat colorectal cancer. These new medications are more effective to treat colon cancer. But multidisciplinary team to diagnose and treat colorectal cancer is key. Dr. David J. Kerr, MD. Colorectal cancer treatment best options and advances. Video interview with leading colorectal cancer Dr. David Kerr (Oxford University). Molecular diagnosis.